• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Aptorum Group Limited - Class A Ordinary Shares (NQ:APM)

    1.280 -0.020 (-1.54%)
    Streaming Delayed Price Updated: 10:53 AM EST, Dec 3, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Aptorum Group Limited - Class A Ordinary Shares

    < Previous 1 2 3 Next >
    News headline image
    DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2025 Conference
    From Aptorum Group Ltd
    Via GlobeNewswire
    News headline image
    Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering
    From Aptorum Group Ltd
    Via GlobeNewswire
    News headline image
    As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives
    From Aptorum Group Ltd
    Via GlobeNewswire
    Aptorum Group Ltd. (NASDAQ: APM) Leading the Way in Wednesday Trading Based on Percentage Gain
    Via Investor Brand Network
    Aptorum Group Ltd. (NASDAQ: APM) Leading the Way in Friday Trading Based on Percentage Gain
    Via Investor Brand Network
    News headline image
    Aptorum Group and DiamiR Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
    From Aptorum Group Ltd
    Via GlobeNewswire
    News headline image
    DiamiR Biosciences and Aptorum Group Announce New York State Approval for DiamiR’s APOE Genotyping Test
    From Aptorum Group Ltd
    Via GlobeNewswire
    News headline image
    Aptorum Group Limited Regains Compliance with NASDAQ’s Minimum Bid Price Requirement
    From Aptorum Group Ltd
    Via GlobeNewswire
    News headline image
    Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement
    From Aptorum Group Ltd
    Via GlobeNewswire
    News headline image
    Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
    From Aptorum Group Ltd
    Via GlobeNewswire
    News headline image
    Aptorum Group Limited Announces Pricing of $3.0 Million Registered Direct Offering
    From Aptorum Group Ltd
    Via GlobeNewswire
    News headline image
    Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2024
    From Aptorum Group Limited
    Via Business Wire
    News headline image
    Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business Update
    From Aptorum Group Limited
    Via Business Wire
    Aptorum Group Ltd. (NASDAQ: APM) is One of Thursday Morning’s Most Active Stocks
    Via Investor Brand Network
    News headline image
    Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy Business
    From Aptorum Group Limited
    Via Business Wire
    News headline image
    Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023
    From Aptorum Group Limited
    Via Business Wire
    News headline image
    Aptorum Group Limited Announces Results of 2023 Annual General Meeting of Shareholders
    From Aptorum Group Limited
    Via Business Wire
    News headline image
    Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023
    From Aptorum Group Limited
    Via Business Wire
    News headline image
    Aptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital Markets
    From Aptorum Group Limited
    Via Business Wire
    News headline image
    Aptorum Group Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for Neuroblastoma
    From Aptorum Group Limited
    Via Business Wire
    News headline image
    Aptorum Group Limited Announces Voluntary Delisting from Euronext Paris
    From Aptorum Group Limited
    Via Business Wire
    News headline image
    Aptorum Group Receives Nasdaq Notification of Minimum Stockholders’ Equity Deficiency
    From Aptorum Group Limited
    Via Business Wire
    News headline image
    Aptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group’s Subsidiary Paths Innovations Limited
    From Aptorum Group Limited
    Via Business Wire
    News headline image
    Aptorum Group Limited Reports 2022 Fiscal Year End Financial Results and Provides Business Update
    From Aptorum Group
    Via Business Wire
    News headline image
    Aptorum Group Enters into Letter of Intent and Term Sheet To Acquire U Group
    From Aptorum Group Limited
    Via Business Wire
    News headline image
    Aptorum Group Limited and ASP Isotopes Inc. Interviews to Air on Bloomberg U.S. on the RedChip Money Report(R)
    Via ACCESSWIRE
    News headline image
    Aptorum Group Announces Completion of Pre-IND Discussions with US FDA on its ALS-4, a First-in-Class Small Molecule Drug Targeting Methicillin Resistant Staphylococcus Aureus
    From Aptorum Group Limited
    Via Business Wire
    News headline image
    Aptorum Group Announces Completion of End of Phase 1 (EOP1) Meeting with US FDA on its SACT-1, a Repurposed Small Molecule Drug Targeting Neuroblastoma
    From Aptorum Group Limited
    Via Business Wire
    News headline image
    Aptorum Group Launches NativusWell®, a Novel Nutraceutical for Menopause, in China
    From Aptorum Group Limited
    Via Business Wire
    News headline image
    Aptorum Group Regains Compliance with Nasdaq Minimum Bid Price and Receives Nasdaq Notification of Minimum Market Value of Publicly Held Shares Deficiency
    From Aptorum Group Limited
    Via Business Wire
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.